Lymphomas are the most common hematological malignancy in the U.S., accounting for an estimated 80,000 new cancer diagnoses and 21,000 deaths each year. These cancers, broadly classified as either Hodgkin lymphomas or non-Hodgkin lymphomas, develop in the lymphatic system. Approximately 85 percent of cases are B-cell lymphomas, meaning they arise in B lymphocytes.
MD Anderson’s B-Cell Lymphoma Moon Shot™ is working toward...
It is estimated that up to half of all cancers may be prevented by making healthy lifestyle choices. Cancer prevention and control is a cornerstone...
Despite a plethora of new and promising treatments available, lung cancer remains the leading cause of cancer death in the United States,...
MD Anderson’s Moon Shots Program™ was established to bring teams of world-class clinicians and researchers together in order to rapidly advance scientific discoveries into the clinic to save patients’ lives. Driving the work of the Moon Shots™ are 10 research platforms that provide unique expertise, technical support and novel infrastructure to the program’s 13 disease-focused initiatives.
One of those platforms is the Cancer Genomics...
Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) encompass a spectrum of diseases characterized by an overproduction of immature...
September is Ovarian Cancer Awareness Month, an annual time to bring attention to the impact of the disease. This year, more than 22,000 women...
A well-trained research workforce is essential for addressing both current and future health challenges in the U.S. However, according to...
Many are aware of the importance of cancer research for the discovery of new therapies and treatment options, but perhaps less well-known...
Excluding skin cancers, prostate cancer is the most commonly diagnosed cancer among men in the United States. According to the American Cancer...
Immunotherapy, which stimulates the patient’s own immune system to attack cancer, has shown promise in treating a variety of cancer types...
Understanding evolution within cancer cells is a longtime interest for Nicholas Navin, Ph.D., an associate professor of Genetics and Bioinformatics...
Each May, Skin Cancer Awareness Month serves as a reminder of how individuals can work to lower their risk of skin cancer – the most common...
Fewer than 30% of the women in the U.S. with abnormal, benign lesions known as atypical hyperplasia (AH) and lobular carcinoma in situ (LCIS...
Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...